News + Filings Holdings
All 13F 13D/G Other
|
MFN Partners Management, LP
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/15/2021 |
SC 13G/A
| MFN Partners Management, LP reports a 4.8% stake in Foley Trasimene Acquisition Corp. |
02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/12/2021 |
SC 13G
| MFN Partners Management, LP reports a 0% stake in Foley Trasimene Acquisition Corp. II |
02/12/2021 |
SC 13G
| MFN Partners Management, LP reports a 13.5% stake in FOLEY TRASIMENE ACQUISITION CORP. |
08/27/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
07/22/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
07/10/2020 |
SC 13G/A
| MFN Partners Management, LP reports a 11.6% stake in FOLEY TRASIMENE ACQUISITION CORP. |
06/05/2020 |
SC 13G
| MFN Partners Management, LP reports a 9.7% stake in Foley Trasimene Acquisition Corp. |
02/13/2020 |
SC 13G/A
| MFN Partners Management, LP reports a 5.4% stake in CYCLERION THERAPEUTICS, INC. |
02/13/2020 |
SC 13G/A
| MFN Partners Management, LP reports a 9.7% stake in ACLARIS THERAPEUTICS, INC. |
10/31/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
04/11/2019 |
SC 13G
| MFN Partners Management, LP reports a 5.5% stake in CYCLERION THERAPEUTICS, INC. |
|
|